AbbVie and ARKX Outperform S&P 500 and JETS in Returns

AbbVie has delivered a 400% return, outperforming the S&P 500 by 139%, while ARKX has also shown higher returns compared to JETS. These analyses highlight significant outperformance by specific investments against broader market indices and sector-specific ETFs.